Assessment of the Concentration of Bone Metabolism Markers: Sclerostin and FGF-23 in Children with Idiopathic Nephrotic Syndrome Treated with Glucocorticosteroids

Figure 2

The plasma concentrations of FGF-23 in the studied groups during relapse and remission.